{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Xiao T"],"funding":["the key research and development program of Zhejiang province"],"pagination":["144"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6712786"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8"],"pubmed_abstract":["<h4>Background</h4><i>Escherichia coli</i> is one of the most common strains of extended-spectrum β-lactam (ESBL)-producing bacteria, and the prevention and treatment of ESBL-producing <i>E. coli</i> infections is an ongoing challenge. The clinical characteristics and outcomes of ESBL-producing <i>E. coli</i> bacteremia in non-transplant patients remain to be elucidated.<h4>Methods</h4>This retrospective study included 491 non-transplant patients with <i>E. coli</i> bloodstream infections (BSIs) from January 2013 to December 2016 and was conducted to investigate the risk factors, clinical features, and outcomes of these infections.<h4>Results</h4>Of the 491 <i>E. coli</i> BSI patients, 57.6% suffered from infections with ESBL-producing strains. A multivariate analysis showed that urinary t"],"journal":["Antimicrobial resistance and infection control"],"pubmed_title":["Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> bacteremia: a retrospective study from 2013 to 2016."],"pmcid":["PMC6712786"],"funding_grant_id":["2015C03032"],"pubmed_authors":["Yang K","Shen P","Ying C","Xiao Y","Ji J","Xiao T","Zhou Y","Zhang S"],"additional_accession":[]},"is_claimable":false,"name":"Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> bacteremia: a retrospective study from 2013 to 2016.","description":"<h4>Background</h4><i>Escherichia coli</i> is one of the most common strains of extended-spectrum β-lactam (ESBL)-producing bacteria, and the prevention and treatment of ESBL-producing <i>E. coli</i> infections is an ongoing challenge. The clinical characteristics and outcomes of ESBL-producing <i>E. coli</i> bacteremia in non-transplant patients remain to be elucidated.<h4>Methods</h4>This retrospective study included 491 non-transplant patients with <i>E. coli</i> bloodstream infections (BSIs) from January 2013 to December 2016 and was conducted to investigate the risk factors, clinical features, and outcomes of these infections.<h4>Results</h4>Of the 491 <i>E. coli</i> BSI patients, 57.6% suffered from infections with ESBL-producing strains. A multivariate analysis showed that urinary t","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019","modification":"2025-04-19T09:38:07.014Z","creation":"2019-09-05T07:05:14Z"},"accession":"S-EPMC6712786","cross_references":{"pubmed":["31467670"],"doi":["10.1186/s13756-019-0599-y"]}}